ConductScience.org, home

Trial · NCT01644643

Participant flow12

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDcIAI:Best Available Therapy15
Overall StudySTARTEDcIAI:CAZ-AVI + Metronidazole12
Overall StudySTARTEDcUTI:Best Available Therapy153
Overall StudySTARTEDcUTI:CAZ-AVI153
Overall StudyCOMPLETEDcIAI:Best Available Therapy13
Overall StudyCOMPLETEDcIAI:CAZ-AVI + Metronidazole12
Overall StudyCOMPLETEDcUTI:Best Available Therapy148
Overall StudyCOMPLETEDcUTI:CAZ-AVI143
Overall StudyNOT COMPLETEDcIAI:Best Available Therapy2
Overall StudyNOT COMPLETEDcIAI:CAZ-AVI + Metronidazole0
Overall StudyNOT COMPLETEDcUTI:Best Available Therapy5
Overall StudyNOT COMPLETEDcUTI:CAZ-AVI10

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01644643/flow